Hsp90 inhibitor as a sensitizer of cancer cells to different therapies

Z Solárová, J MOJžiš, P SOLáR - … Journal of Oncology, 2015 - spandidos-publications.com
Hsp90 is a molecular chaperone that maintains the structural and functional integrity of
various client proteins involved in signaling and many other functions of cancer cells. The …

Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia—the possibility to target several kinases through inhibition …

AK Brenner, H Reikvam, A Lavecchia, Ø Bruserud - Molecules, 2014 - mdpi.com
The cell division cycle 25 (CDC25) phosphatases include CDC25A, CDC25B and CDC25C.
These three molecules are important regulators of several steps in the cell cycle, including …

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death

SK Heo, EK Noh, JY Kim, YK Jeong, JC Jo, Y Choi… - Scientific reports, 2017 - nature.com
Dasatinib and radotinib are oral BCR-ABL tyrosine kinase inhibitors that were developed as
drugs for the treatment of chronic myeloid leukemia. We report here that the c-KIT (CD117) …

The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells

C Campanella, A D'Anneo, AM Gammazza… - …, 2015 - pmc.ncbi.nlm.nih.gov
HSP60 undergoes changes in quantity and distribution in some types of tumors suggesting
a participation of the chaperonin in the mechanism of transformation and cancer …

Interruption of p53-MDM2 interaction by Nutlin-3a in human lymphoma cell models initiates a cell-dependent global effect on transcriptome and proteome level

K Psatha, L Kollipara, E Drakos, E Deligianni… - Cancers, 2023 - mdpi.com
Simple Summary The activation of wild-type p53 protein in human lymphoma is a promising
therapeutic strategy. A precise interruption of a protein–protein interaction, such as the p53 …

HSP60 in cancer: A promising biomarker for diagnosis and a potentially useful target for treatment

B Sun, G Li, Q Yu, D Liu, X Tang - Journal of Drug Targeting, 2022 - Taylor & Francis
Heat shock proteins (HSPs), most of which are molecular chaperones, are highly conserved
proteins produced by cells under physiological stress or pathological conditions. HSP60 (57 …

Helping the released guardian: drug combinations for supporting the anticancer activity of HDM2 (MDM2) antagonists

J Kocik, M Machula, A Wisniewska, E Surmiak… - Cancers, 2019 - mdpi.com
The protein p53, known as the “Guardian of the Genome”, plays an important role in
maintaining DNA integrity, providing protection against cancer-promoting mutations …

Discovery of novel SIRT1/2 inhibitors with effective cytotoxicity against human leukemia cells

H Cai, Y Wang, J Zhang, Z Wei, T Yan… - Journal of Chemical …, 2023 - ACS Publications
The sirtuin enzyme family members, SIRT1 and SIRT2, play both tumor-promoting and tumor-
suppressing roles, depending on the context and experimental conditions. Compounds that …

The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276

R Li, P Zatloukalova, P Muller, M Gil-Mir, S Kote… - Cellular & molecular …, 2020 - Springer
Background The links between the p53/MDM2 pathway and the expression of pro-
oncogenic immune inhibitory receptors in tumor cells are undefined. In this report, we …

Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows

E Aasebø, O Mjaavatten, M Vaudel, Y Farag… - Journal of …, 2016 - Elsevier
MS-based proteomic studies aiming for the discovery of acute myeloid leukemia (AML)
biomarkers require sample processing that can assure an optimal proteome coverage and …